Patients with neurological involvement require more intensive initial treatment with injections on alternate days until no further improvement occurs
Another review of studies involving BPC-157, as well as TB-500, GHK-Cu, and several other peptides, similarly found a lack of evidence to support clinical use of the substances
(, CMR Bill of Lading)
Its value in a clinical setting comes from what it is not: it does not disrupt appetite, hormones, insulin, or IGF-1
Chemotherapy with drugs like 5-fluorouracil has also been associated with acute thiamine deficiency by disrupting thiamine activation, so oncology patients receiving such therapy might receive parenteral thiamine supplementation as part of this B-Complex if needed
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C